The Updated NHS Commercial Framework for New Medicines

March 3, 2025

Re-Launch of UK’s Innovative Licensing and Access Pathway (“ILAP”)

February 14, 2025

MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?

February 13, 2025

MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?

February 12, 2025

European Commission Consults on Update to Pharmacovigilance Rules

January 9, 2025

Are you Windsor Framework ready? A focus on pharmaceutical supply chains and promotional material

December 18, 2024

MHRA Consults on New UK Pre-Market Medical Device Measures

December 2, 2024

MHRA Consults on New UK Pre-Market Medical Device Measures

November 28, 2024

UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?

October 28, 2024

UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?

October 28, 2024